Article Versions Notes

Boelaert J, Schepers E, Glorieux G, Eloot S, Vanholder R, Lynen F. Response to Tsikas et al. Comments on Boelaert et al. Determination of Asymmetric and Symmetric Dimethylarginine in Serum from Patients with Chronic Kidney Disease: UPLC–MS/MS versus ELISA. Toxins 2016, 8, 149. Toxins. 2016; 8(11):312. https://doi.org/10.3390/toxins8110312

Boelaert, Jente, Eva Schepers, Griet Glorieux, Sunny Eloot, Raymond Vanholder, and Frédéric Lynen. 2016. "Response to Tsikas et al. Comments on Boelaert et al. Determination of Asymmetric and Symmetric Dimethylarginine in Serum from Patients with Chronic Kidney Disease: UPLC–MS/MS versus ELISA. Toxins 2016, 8, 149" Toxins 8, no. 11: 312. https://doi.org/10.3390/toxins8110312

Boelaert, J., Schepers, E., Glorieux, G., Eloot, S., Vanholder, R., & Lynen, F. (2016). Response to Tsikas et al. Comments on Boelaert et al. Determination of Asymmetric and Symmetric Dimethylarginine in Serum from Patients with Chronic Kidney Disease: UPLC–MS/MS versus ELISA. Toxins 2016, 8, 149. Toxins, 8(11), 312. https://doi.org/10.3390/toxins8110312